🇺🇸 FDA
Patent

US 7696246

Bicyclic androgen and progesterone receptor modulator compounds and methods

granted A61PA61P13/08A61P15/00

Quick answer

US patent 7696246 (Bicyclic androgen and progesterone receptor modulator compounds and methods) held by Ligand Pharmaceuticals Incorporated expires Mon Apr 08 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Ligand Pharmaceuticals Incorporated
Grant date
Tue Apr 13 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 08 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
32
CPC classes
A61P, A61P13/08, A61P15/00, A61P15/04, A61P15/08